Admission Date:  [**2164-6-17**]              Discharge Date:   [**2164-6-24**]

Date of Birth:  [**2110-9-28**]             Sex:   F

Service: SURGERY

Allergies:
No Known Allergies / Adverse Drug Reactions

Attending:[**First Name3 (LF) 4691**]
Chief Complaint:
Abdominal pain

Major Surgical or Invasive Procedure:
exploratory laparotomy with [**First Name4 (NamePattern1) 27175**] [**Last Name (NamePattern1) **] of perforated D.U.


History of Present Illness:
53 F who presents as a transfer from [**Hospital3 1280**] Hospital with 24
hours of abdominal pain. Pain crampy and diffuse. Has worsened
throughout the day. No radiation. She was hypotensive at her
jail and at [**Hospital3 1280**] Hospital. CXR at [**Hospital3 1280**] shows gross
free intraperitoneal air. She denies fevers, chills, nausea,
vomiting, diarrhea, constipation, or any other symptoms. Last
bowel movement last evening. Of note, she has been taking 800 mg
of motrin TID for the past 2 weeks.


Past Medical History:
PMH: HIV, HCV, RLL lung cancer, asthma, anxiety PSH: RLL lung
cancer resection via VATS, L. adrenalectomy for ? metastatic
lung ca, laparoscopic cholecystectomy, appendectomy, R. shoulder
surgery


Social History:
SH: currently in jail; h/o IVDA (heroine and cocaine - last use
4
weeks ago); smokes [**1-15**] ppd x 40 years; h/o EtOH abuse but not in
many years


Family History:
n/c

Physical Exam:
On admission:
A&O x 3, uncomfortable, pale
RRR
Lungs CTAB, R. VATS scars all well healed
Abdomen soft, distended, hypoactive bowel sounds, tender
diffusely with voluntary guarding
L. flank scar well healed
LE warm, no edema

On discharge:
99.8  99.6  110  132/85  18  97%2L
Gen: AAOx3. NAD
Card: RRR
Pulm: Breath sounds present b/l.
Abd: Soft. NT.ND. Incision with lower pole with WTD dressing.
Upper poles c/d/i s/ drainage. LLQ site of former JP drain
without drainge.


Pertinent Results:
137  104  5
--------------<98
3.4  24  0.4

Ca: 7.4 Mg: 1.7 P: 2.0

[**2164-6-17**] 02:00AM URINE  MUCOUS-MANY
[**2164-6-17**] 02:00AM URINE  HYALINE-166* BROAD-4*
[**2164-6-17**] 02:00AM URINE  RBC-1 WBC-43* BACTERIA-FEW YEAST-NONE
EPI-0 TRANS EPI-1
[**2164-6-17**] 02:00AM URINE  BLOOD-SM  NITRITE-NEG PROTEIN-100
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-2* PH-5.5
LEUK-NEG
[**2164-6-17**] 02:00AM URINE  COLOR-Red APPEAR-Hazy SP [**Last Name (un) 155**]-1.017
[**2164-6-17**] 02:00AM   PT-19.2* PTT-33.2 INR(PT)-1.7*
[**2164-6-17**] 02:00AM   PLT SMR-NORMAL PLT COUNT-193
[**2164-6-17**] 02:00AM   HYPOCHROM-NORMAL ANISOCYT-NORMAL POIKILOCY-3+
MACROCYT-NORMAL MICROCYT-NORMAL POLYCHROM-NORMAL BURR-2+
TEARDROP-1+
[**2164-6-17**] 02:00AM   NEUTS-48* BANDS-38* LYMPHS-7* MONOS-6 EOS-0
BASOS-0 ATYPS-0 METAS-1* MYELOS-0
[**2164-6-17**] 02:00AM   WBC-8.2 RBC-5.01 HGB-14.5 HCT-42.6 MCV-85
MCH-28.9 MCHC-34.0 RDW-14.4
[**2164-6-17**] 02:00AM   estGFR-Using this
[**2164-6-17**] 02:00AM   GLUCOSE-108* UREA N-31* CREAT-2.2* SODIUM-137
POTASSIUM-3.8 CHLORIDE-107 TOTAL CO2-18* ANION GAP-16
[**2164-6-17**] 02:30AM   GLUCOSE-101 LACTATE-3.2* NA+-136 K+-3.3*
CL--107
[**2164-6-17**] 05:39AM   freeCa-0.99*
[**2164-6-17**] 05:39AM   HGB-10.5* calcHCT-32
[**2164-6-17**] 05:39AM   GLUCOSE-126* LACTATE-3.3* NA+-133* K+-2.7*
CL--109
[**2164-6-17**] 05:39AM   PO2-109* PCO2-44 PH-7.24* TOTAL CO2-20* BASE
XS--8
[**2164-6-17**] 05:39AM   PO2-109* PCO2-44 PH-7.24* TOTAL CO2-20* BASE
XS--8
[**2164-6-17**] 05:39AM   PO2-109* PCO2-44 PH-7.24* TOTAL CO2-20* BASE
XS--8
[**2164-6-17**] 06:58AM   PT-22.0* PTT-40.4* INR(PT)-2.0*
[**2164-6-17**] 06:58AM   PLT COUNT-128*
[**2164-6-17**] 06:58AM   WBC-1.7*# RBC-4.33 HGB-12.7 HCT-37.1 MCV-86
MCH-29.3 MCHC-34.2 RDW-14.4
[**2164-6-17**] 06:58AM   CALCIUM-7.9* PHOSPHATE-4.4 MAGNESIUM-5.8*
[**2164-6-17**] 06:58AM   GLUCOSE-123* UREA N-25* CREAT-1.4* SODIUM-139
POTASSIUM-2.7* CHLORIDE-111* TOTAL CO2-20* ANION GAP-11
[**2164-6-17**] 07:10AM   freeCa-1.26
[**2164-6-17**] 07:10AM   LACTATE-2.9*
[**2164-6-17**] 07:10AM   TYPE-ART TEMP-33.9 O2-50 PO2-77* PCO2-32*
PH-7.39 TOTAL CO2-20* BASE XS--4 INTUBATED-INTUBATED
[**2164-6-17**] 11:17AM   TYPE-ART PO2-130* PCO2-30* PH-7.42 TOTAL
CO2-20* BASE XS--3
[**2164-6-17**] 11:30AM URINE  OSMOLAL-402
[**2164-6-17**] 11:30AM URINE  HOURS-RANDOM UREA N-342 CREAT-132
SODIUM-10 POTASSIUM-68 CHLORIDE-36
[**2164-6-17**] 02:10PM   PT-21.9* PTT-37.7* INR(PT)-2.0*
[**2164-6-17**] 02:10PM   PLT COUNT-179
[**2164-6-17**] 02:10PM   WBC-2.5* RBC-4.29 HGB-12.7 HCT-36.4 MCV-85
MCH-29.5 MCHC-34.8 RDW-14.6
[**2164-6-17**] 02:10PM   CALCIUM-6.7* PHOSPHATE-3.6 MAGNESIUM-4.4*
[**2164-6-17**] 02:10PM   GLUCOSE-94 UREA N-24* CREAT-1.2* SODIUM-138
POTASSIUM-3.8 CHLORIDE-113* TOTAL CO2-18* ANION GAP-11
[**2164-6-17**] 02:14PM   freeCa-1.09*
[**2164-6-17**] 02:14PM   GLUCOSE-93 LACTATE-1.2
[**2164-6-17**] 02:14PM   TYPE-ART PO2-118* PCO2-28* PH-7.45 TOTAL
CO2-20* BASE XS--2
[**2164-6-17**] 04:57PM   TYPE-ART PO2-124* PCO2-31* PH-7.41 TOTAL
CO2-20* BASE XS--3

Brief Hospital Course:
Discharge Summary

The patient was admitted to the General Surgical Service for
evaluation and treatment. After a brief, uneventful stay in the
PACU, the patient arrived on the floor NPO, on IV fluids and
antibiotics, with a foley catheter. The patient was
hemodynamically stable.

Neuro: The patient received a dilaudid PCA with good effect and
adequate pain control. When tolerating oral intake, the patient
was transitioned to oral pain medications.

CV: The patient remained stable from a cardiovascular
standpoint; vital signs were routinely monitored.

Pulmonary: The patient initially had increased upper airway
secretions due to which she would deasaturate especially when
sleeping. The patient was given nebulizers, including albuterol,
mucomyst, and atrovent which improved her symptoms
significantly. She therafter remained stable; vital signs were
routinely monitored. Good pulmonary toilet, early ambulation and
incentive spirometry were encouraged throughout hospitalization.

GI/GU/FEN: Post-operatively, the patient was made NPO with IV
fluids. Diet was advanced when appropriate. Patient's intake and
output were closely monitored, and IV fluid was adjusted when
necessary. Electrolytes were routinely followed, and repleted
when necessary.

ID: The patient's white blood count and fever curves were
closely watched for signs of infection. The lower pole of the
wound was noted to have drainage. Several staples were removed
and the wound was packed with gauze, in a wet to dry manner,
which was well tolerated by the pateint. The patient was kept on
Cipro flagyl for a total of seven days. This was stopped prior
to discharge.

Endocrine: The patient's blood sugar was monitored throughout
here stay.

Hematology: The patient's complete blood count was examined
routinely; no transfusions were required.

Prophylaxis: The patient received subcutaneous heparin and
venodyne boots were used during this stay; she was encouraged to
get up and ambulate as early as possible.

At the time of discharge, the patient was doing well, afebrile
with stable vital signs. The patient was tolerating a regular
diet, ambulating, voiding without assistance, and pain was well
controlled. The patient received discharge teaching and
follow-up instructions with understanding verbalized and
agreement with the discharge plan.

Medications on Admission:
benadryl 75', klonopin 0.5"', motrin 800"', robaxin 1500"',
Atripla 1 tab daily, methadone wean (? off), bentyl, xanax,
clonidine


Discharge Medications:
1. efavirenz 600 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).

2. emtricitabine-tenofovir 200-300 mg Tablet Sig: One (1) Tablet
PO DAILY (Daily).
3. hydromorphone 2 mg Tablet Sig: 1-2 Tablets PO Q3H (every 3
hours) as needed for pain for 2 weeks.
Disp:*25 Tablet(s)* Refills:*0*
4. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2
times a day) as needed for constipation for 3 weeks.
5. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a
day) as needed for constipation for 2 weeks.
6. bisacodyl 5 mg Tablet, Delayed Release (E.C.) Sig: Two (2)
Tablet, Delayed Release (E.C.) PO DAILY (Daily) as needed for
constipation for 2 weeks.
7. Xanax 0.5 mg Tablet Oral
8. Klonopin 0.5 mg Tablet Sig: One (1) Tablet PO three 